	自己資本および準備金		日付
Acadia Pharmaceuticals	USD 1.31B	58.54M	2026-06
Adma Biologics	USD 408.21M	17.88M	2026-06
ALKERMES	USD 1.81B	57.02M	2026-06
Alterity Therapeutics Limited	AUD 36.21M	18.58M	2025-12
AstraZeneca	USD 50.3B	2.96B	2026-06
BioCryst Pharmaceuticals	USD -454.29M	99.55M	2026-06
Bristol-Myers Squibb	USD 22.32B	2.25B	2026-06
Cipla	INR 344.32B	15.13B	2026-03
Clal Biotechnology	ILS 121.41M	4.62M	2023-12
Compugen	USD 95.35M	7.38M	2026-03
CSL	USD 18.66B	2.75B	2025-12
Eli Lilly	USD 33.88B	2.68B	2026-06
GlaxoSmithKline	GBP 17.64B	223M	2026-06
Grifols	EUR 6.21B	133.12M	2025-12
Halozyme Therapeutics	USD 143.54M	76.09M	2026-06
Ionis Pharmaceuticals	USD 439.74M	51.68M	2026-06
J&J	USD 84.97B	3.78B	2026-06
Merck	USD 41.93B	3.94B	2026-06
Minerva Neurosciences	USD -140.75M	106.17M	2025-12
Neurocrine Biosciences	USD 3.69B	286.2M	2026-06
Novartis	USD 41.95B	3.02B	2026-06
Novavax	USD -190.71M	45.94M	2026-06
Pfizer	USD 85.19B	4.91B	2026-06
Roche Holding	CHF 32.69B	1.11B	2026-06
Sanofi	EUR 69.57B	3.24B	2026-06
Takeda	JPY 7.56T	215.7B	2026-06
Vanda Pharmaceuticals	USD 327.19M	138.81M	2025-12